cardio:ccb:felodipine
Felodipine
Felodipine is a Dihydropyridine Calcium Channel Blocker (DHP CCB).
It primarily causes arterial vasodilation and reduces systemic vascular resistance.
Used in:
Mechanism of Action
Felodipine blocks L-type calcium channels in vascular smooth muscle.
This results in:
- ↓ Intracellular calcium
- Arterial vasodilation
- ↓ Systemic Vascular Resistance (SVR)
- ↓ Afterload
Minimal direct effect on:
- SA node
- AV node
- Myocardial contractility
Primary action = vascular.
Pharmacologic Profile
Formulation:
- Extended-release (standard)
Half-life:
- Intermediate (longer than nifedipine IR)
- Once-daily dosing
Less reflex tachycardia than short-acting Nifedipine.
Clinical Use
Hypertension:
- Alternative to Amlodipine
- Often combined with:
Stable Angina:
- Reduces afterload
- Improves myocardial oxygen balance
Adverse Effects
Common:
- Peripheral edema
- Headache
- Flushing
- Dizziness
Mechanism of edema:
- Arteriolar dilation without venous dilation
- Increased capillary hydrostatic pressure
Less AV nodal suppression than:
Felodipine vs Other DHPs
- Longer half-life
- Very smooth BP control
- Faster onset
- Short-acting form associated with reflex tachycardia
Felodipine:
- Extended-release
- Reliable antihypertensive option
- Pure vasodilator profile
Clinical Pearls
- DHP CCB
- Arterial vasodilator
- Once-daily dosing
- Causes peripheral edema
- No AV nodal slowing
- Good alternative to amlodipine
Related
cardio/ccb/felodipine.txt · Last modified: by andrew2393cns
